SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-19-050879
Filing Date
2019-02-26
Accepted
2019-02-26 08:55:06
Documents
4
Effectiveness Date
2019-02-26

Document Format Files

Seq Description Document Type Size
1 S-8 d703345ds8.htm S-8 64920
2 EX-5.1 d703345dex51.htm EX-5.1 8582
3 EX-23.2 d703345dex232.htm EX-23.2 1591
4 GRAPHIC g703345g32v41.jpg GRAPHIC 4547
  Complete submission text file 0001193125-19-050879.txt   82549
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-229861 | Film No.: 19631744
SIC: 2836 Biological Products, (No Diagnostic Substances)